Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Aβ stabilization

Journal of Clinical Investigation

Volumn 100, Issue 2, 1997, Pages 310-320

  LaFerla, Frank M ^a,c   Troncoso, Juan C ^b   Strickland, Dudley K ^a   Kawas, Claudia H ^b   Jay, Gilbert ^a  

^a HOLLAND LABORATORY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Apoptotic cell death; Glycoprotein 330; amyloid protein

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CELL SURFACE RECEPTOR; DNA FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NERVE CELL NECROSIS; PRIORITY JOURNAL;

EID: 0030793522     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119536     Document Type: Article

References (78)

1. Yankner, B.A. 1996. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:921-932.
2. Glenner, G.G., and C.W. Wong. 1984. Alzheimer's disease: initial report of the purification of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:885-890.
3. Masters, C.L., G. Simms, N.A. Weinman, G. Multhaup, B.L. McDonald, and K. Beyreuther. 1985. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:4245-4249.
4. Iwatsubo, T., A. Odaka, N. Suzuki, M. Hidehiro, N. Nukina, and Y. Ihara. 1994. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron. 13:45-53.
5. Haass, C., M. Schlossmacher, A.Y. Hung, C. Vigo-Pelfrey, A. Mellon, B.L. Ostaszewski, I. Lieberberg, E.H. Koo, D. Schenk, D.B. Teplow, and D.J. Selkoe. 1992. Amyloid βw-peptide is produced by cultured cells during normal metabolism. Nature (Lond.). 359:322-325.
6. Shoji, M., T.E. Golde, J. Ghiso, T.T. Cheung, S. Estus, L.M. Shafer, X. Cai, D.M. McKay, R. Tintner, B. Frangione, and S.G. Younkin. 1992. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science (Wash. DC). 258:126-129.
7. Busciglio, J., D.H. Gabuzda, P. Matsudaira, and B.A. Yankner. 1993. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. USA. 90:2092-2096.
8. Seubert, P., C. Vigo-Pelfrey, F. Esch, M. Lee, H. Dovey, D. Davis, S. Sinha, M. Schlossmacher, J. Whaley, C. Swindlehurst, et al. 1992. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature (Lond.). 359:325-327.
9. DeKosky, S.T., and S.W. Scheff. 1990. Synapse loss in frontal lobe biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27: 457-464.
10. Terry, R.D., E. Maslieh, D.P. Salmon, N. Butters, R. DeTheresa, R. Hill, L.A. Hansen, and R. Katzman. 1991. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 4:572-580.
11. Scheff, S.W., and D.A. Price. 1993. Synapse loss in the temporal lobe in Alzheimer's disease. Ann. Neurol. 33:190-199.
12. Cummings, B.J., and C.W. Cotman. 1995. Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet. 346: 1524-1528.
13. Yankner, B.A., L.R. Dawes, S. Fisher, K.L. Villa, G.M.L. Oster, and R.L. Neve. 1989. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science (Wash. DC). 245:417-420.
14. Loo, D.T., A. Copani, C.J. Pike, E.R. Whittemore, A.J. Walencewicz, and C.W. Cotman. 1993. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA. 90:7951-7955.
15. LaFerla, F.M., B.T. Tinkle, C.J. Bieberich, C.C. Haudenschild, and G. Jay. 1995. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet. 9:21-30.
16. LaFerla, F.M., C.A. Kappel-Hall, L. Ngo, and G. Jay. 1996. Extracellular deposition of β-amyloid upon p53-dependent neuronal cell death in transgenic mice. J. Clin. Invest. 98:1626-1632.
17. Gavrieli, Y., Y. Sherman, and S.S. Ben. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
18. Charriaut-Marlangue, C., and Y. Ben-Ari. 1995. A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport. 7:61-64.
19. Su, J.H., A.J. Anderson, B.J. Cummings, and C.W. Cotman. 1994. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport. 5:2529-2533.
20. Lassmann, H., C. Bancher, H. Breitschopf, J. Wegiel, M. Bobinski, K. Jellinger, and H.M. Wisniewski. 1995. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 89:35-41.
21. Smale, G., N.R. Nichols, D.R. Brady, C.E. Finch, and W.J. Horton. 1995. Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol. 133:225-230.
22. Han, S.H., C. Hulette, A.M. Saunders, G. Einstein, M. Pericak-Vance, W.J. Strittmatter, A.D. Roses, and D.E. Schmechel. 1994. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp. Neurol. 128:13-26.
23. Han, S.-H., G. Einstein, K.H. Weisgraber, W.J. Strittmatter, A.M. Saunders, M. Pericak-Vance, A.D. Roses, and D.E. Schmechel. 1994. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J. Neuropathol. Exp. Neurol. 53:535-544.
24. Mirra, S.S., A. Heyman, and D. McKeel. 1991. The consortium to establish a registry for Alzheimer's disease (CERAD) part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology. 41:479-486.
25. Wijsman, J.H., R.R. Jonker, R. Keijzer, C.J.H. van DeVelde, C.J. Cornelisse, and J.H. van Dierendock. 1993. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J. Histochem. Cytochem. 41:7-21.
26. Gold, R., M. Schmied, G. Giegerich, H. Breitschopf, H.P. Hartung, K.V. Toyka, and H. Lassmann. 1994. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 71:219-225.
27. Kim, K.S., D.L. Miller, V.J. Sapienza, C.J. Chen, C. Bai, I. Grundke-Iqbal, J.R. Currie, and H.M. Wisniewski. 1988. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Commun. 2:121-130.
28. Milne, R.W., P.H. Douste-Blazy, Y.L. Marcel, and L. Retegul. 1981. Characterization of monoclonal antibodies against human apolipoprotein E. J. Clin. Invest. 68:111-117.
29. Kounnas, M.Z., C.C. Haudenschild, D.K. Strickland, and W.S. Argraves. 1994. Immunological localization of glycoprotein 330, low density lipoprotein receptor related protein and 39 kDa receptor associated protein in embryonic mouse tissue. In Vivo. 8:343-352.
30. Strickland, D.K., J.D. Ashcom, S. Williams, W.H. Burgess, M. Migliorini, and W.S. Argraves. 1990. Sequence identity between the α2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 265:17401-17404.
31. Kounnas, M.Z., R.E. Morris, M.R. Thompson, D.J. Fitzgerald, D.K. Strickland, and C.B. Saelinger. 1992. The α2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J. Biol. Chem. 267:12420-12423.
32. 2+ and monoclonal antibodies but not lipoproteins. J. Biol. Chem. 262:17443-17449.
33. Battey, F.D., M.E. Gafuels, D.J. Fitzgerald, W.S. Argraves, D.A. Chappell, J.F. Strauss, and D.K. Strickland. 1994. The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. J. Biol. Chem. 269:23268-23273.
34. Majno, G., and I. Joris. 1995. Apoptosis, oncosis, and necrosis. Am. J. Pathol. 146:3-15.
35. Dowson, J.H. 1982. Neuronal lipofuscin accumulation in aging and Alzheimer dementia: a pathogenic mechanism. Br. J. Psychiatry. 140:142-148.
36. Mahley, R.W. 1988. Apolipoprotein E: cholesterol transport with expanded role in cell biology. Science (Wash. DC). 240:622-630.
37. Strittmatter, W.J., A.M. Saunders, D. Schmechel, V.M. Pericak, J. Enghild, G.S. Salvesen, and A.D. Roses. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1977-1981.
38. LaDu, M.J., M.T. Falduto, A.M. Manelli, C.A. Reardon, G.S. Getz, and D.E. Frail. 1994. Isoform-specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269:23403-23406.
39. Ma, J., A. Yee, J. Brewer, S. Das, and H. Potter. 1994. The amyloidassociated proteins α-antichymotrypsin and apolipoprotein E promote the assembly of the Alzheimer β-protein into filaments. Nature (Lond.). 373:92-94.
40. Sanan, D.A., K.H. Weisgraber, S.J. Russell, R.W. Mahley, D. Huang, A. Saunders, D. Schmechel, T. Wisniewski, B. Frangione, A.D. Roses, and W.J. Strittmatter. 1994. Apolipoprotein E associates with β-amyloid peptide of Alzheimer's disease to form novel monofibrils. J. Clin. Invest. 94:860-869.
41. Naslund, J., J. Thyberg, L.O. Tjernberg, C. Wernstedt, A.R. Karlstrom, N. Bogdanovic, S.E. Gandy, L. Lannfelt, L. Terenius, and C. Nordstedt. 1995. Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain. Neuron. 15:219-228.
42. Boyles, J.K. 1985. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76:1501-1513.
43. Pitas, R.E. 1987. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochem. Biophys. Acta. 917:148-161.
44. Brown, M.S., and J.L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science (Wash. DC). 232:34-47.
45. Kreiger, M., and J. Herz. 1994. Structures and functions of multiligand lipoprotein receptors: macrophages, scavenger receptors, and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63:601-637.
46. Takahashi, S., Y. Kawarabayasi, T. Nakai, J. Sakai, and T. Yamamoto. 1993. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc. Natl. Acad. Sci. USA. 89:9252-9256.
47. Kowal, R.C., J. Herz, J.L. Goldstein, V. Esser, and M.S. Brown. 1989. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc. Natl. Acad. Sci. USA. 86:5810-5814.
48. Beisiegel, U., W. Weber, G. Ihrke, J. Herz, and K.K. Stanley. 1989. The LDL receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature (Lond.). 341:152-164.
49. Willnow, T.E., J.L. Goldstein, K. Orth, M.S. Brown, and J. Herz. 1992. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem. 267:26172-26180.
50. Saito, A., S. Pierromonoco, A.K.C. Loo, and M.G. Farquhar. 1994. Complete cloning and sequencing of rat gp330/megalin, a distinctive member of the low density lipoprotein receptor gene family. Proc. Natl. Acad. Sci. USA. 91:9725-9729.
51. Zheng, G., D.R. Bachinsky, and I. Stamenkovic. 1994. Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/α2MR, and the receptor-associated protein (RAP). J. Histochem. Cytochem. 42:531-542.
52. Hyman, B.T., K. Marzloff, and P.V. Arriagada. 1993. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J. Neuropathol. Exp. Neurol. 52:594-600.
53. Terry, R.D. 1996. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J. Neuropathol. Exp. Neurol. 55:1023-1025.
54. Martin, B.L., G. Schrader-Fischer, J. Busciglio, M. Duke, P. Paganetti, and B.A. Yankner. 1995. Intracellular accumulation of β-amyloid in cells expressing the Swedish mutant amyloid precursor protein. J. Biol. Chem. 270: 26727-26730.
55. Wertkin, A.M., R.S. Turner, S.J. Pleasure, T.E. Golde, S.G. Younkin, J.Q. Trojanowski, and V.M.-Y. Lee. 1993. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular β-amyloid or A4 peptides. Proc. Natl. Acad. Sci. USA. 90:9513-9517.
56. Knauer, M.F., B. Soreghan, D. Burdick, J. Kosmoski, and C.G. Glabe. 1992. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/β protein. Proc. Natl. Acad. Sci. USA. 89:7437-7441.
57. Maruyama, K., K. Terakado, M. Usami, and K. Yoshikawa. 1990. Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid protein precursor. Nature (Lond.). 347:566-569.
58. Martin, L.J., C.A. Pardo, L.C. Cork, and D.L. Price. 1994. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 145: 1358-1381.
59. Cummings, B.J., J.H. Su, C.W. Cotman, R. White, and M.J. Russell. 1993. β-amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease. Neurobiol. Aging. 14:547-560.
60. Sparks, D.L., S.W. Scheff, J.C. Hunsaker, H. Liu, T. Landers, and D.R. Gross. 1994. Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 126:88-94.
61. Grundke-Iqbal, I., K. Iqbal, L. George, Y.C. Tung, K.S. Kim, and H.M. Wisniewski. 1989. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 86:2853-2857.
62. Perry, G., P. Cras, S.L. Siedlak, M. Tabaton, and M. Kawai. 1992. β protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. Am. J. Pathol. 140:283-289.
63. Burdick, D., B. Soreghan, M. Kwon, J. Kosmoski, M. Knauer, A. Henschen, J. Yates, C. Cotman, and C. Glabe. 1992. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 267:546-554.
64. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science (Wash. DC). 271:521-525.
65. Deng, G., C.J. Pike, and C.W. Cotman. 1996. Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells. FEBS (Fed. Eur. Biochem. Soc.) Lett. 397:50-54.
66. Corder, E.H., A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and V.M. Pericak. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (Wash. DC). 261:921-923.
67. Rebeck, G.W., J.S. Reiter, D.K. Strickland, and B.T. Hyman. 1993. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 11:575-580.
68. Payami, H., J. Kaye, L.L. Heston, T.D. Bird, and G.D. Schellenberg. 1993. Apolipoprotein E genotype and Alzheimer's disease. Lancet. 342:738.
69. Ohm, T.G., M. Kirca, J. Bohl, H. Scharnagl, W. Grob, and W. Marz. 1995. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience. 66:583-587.
70. Weisgraber, K.H., T.L. Innerarity, and R.W. Mahley. 1982. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J. Biol. Chem. 257:2518-2521.
71. Jensen, T.G., A.D. Roses, and A.L. Jorgensen. 1994. Apolipoprotein E uptake and degradation via chloroquine-sensitive pathway in cultivated monkey cells overexpressing low density lipoprotein receptor. Neurosci. Lett. 180: 193-196.
72. Cataldo, A.M., D.J. Hamilton, J.L. Barnett, P.A. Paskevich, and R.A. Nixon. 1996. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J. Neurosci. 16:186-199.
73. Roses, A.D. 1995. Perspective: on the metabolism of apolipoprotein E and the Alzheimer diseases. Exp. Neurol. 132:149-156.
74. Scharnagl, H., K. Winkler, M. Huttinger, et al. 1996. The βA4 amyloid peptide enhances cellular uptake of apolipoprotein E-containing lipoproteins by the low-density lipoprotein receptor-related protein/alpha-2-macroglobulin receptor. In Apolipoprotein E and Alzheimer's Disease. A. Roses, K. Weisgraber, and Y. Christen, editors. Springer-Verlag, Berlin, Germany. 136-144.
75. Wisniewski, T., A. Golabek, E. Matsubara, J. Ghiso, and B. Frangione. 1993. Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid. Biochem. Biophys. Res. Commun. 192:359-365.
76. Strittmatter, W.J., K.H. Weisgraber, D.Y. Huang, L.M. Dong, G.S. Salvesen, V.M. Pericak, D. Schmechel, A.M. Saunders, D. Goldgaber, and A.D. Roses. 1993. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:8098-8102.
77. Namba, Y., M. Tomonaga, H. Kawasaki, E. Otomo, and K. Ikeda. 1991. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:163-166.
78. Kounnas, M.Z., R.D. Moir, G.W. Rebeck, A.I. Bush, W.S. Argraves, R.E. Tanzi, B.T. Hyman, and D.K. Strickland. 1995. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell. 82:331-340.